These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7543094)
21. Lipopolysaccharide interactions of C-terminal peptides from human thrombin. Singh S; Kalle M; Papareddy P; Schmidtchen A; Malmsten M Biomacromolecules; 2013 May; 14(5):1482-92. PubMed ID: 23537377 [TBL] [Abstract][Full Text] [Related]
22. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883 [TBL] [Abstract][Full Text] [Related]
23. Lipid A Remodeling Is a Pathoadaptive Mechanism That Impacts Lipopolysaccharide Recognition and Intracellular Survival of Burkholderia pseudomallei. Norris MH; Somprasong N; Schweizer HP; Tuanyok A Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037795 [No Abstract] [Full Text] [Related]
24. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. Tobias PS; Soldau K; Ulevitch RJ J Biol Chem; 1989 Jun; 264(18):10867-71. PubMed ID: 2471708 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of TNF-triggering activity of lipopolysaccharide by a proteinaceous factor from normal mouse liver extract. Satoh M; Matsumura T; Nakamoto M; Yamazaki M J Immunol; 1995 Jul; 155(2):877-85. PubMed ID: 7608565 [TBL] [Abstract][Full Text] [Related]
26. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity. Li P; Ho B; Ding JL J Endotoxin Res; 2007; 13(3):150-7. PubMed ID: 17621557 [TBL] [Abstract][Full Text] [Related]
27. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor. Ried C; Wahl C; Miethke T; Wellnhofer G; Landgraf C; Schneider-Mergener J; Hoess A J Biol Chem; 1996 Nov; 271(45):28120-7. PubMed ID: 8910426 [TBL] [Abstract][Full Text] [Related]
28. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400 [TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. Han J; Mathison JC; Ulevitch RJ; Tobias PS J Biol Chem; 1994 Mar; 269(11):8172-5. PubMed ID: 7510680 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction. Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844 [TBL] [Abstract][Full Text] [Related]
31. Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes. Gutsmann T; Haberer N; Carroll SF; Seydel U; Wiese A Biol Chem; 2001 Mar; 382(3):425-34. PubMed ID: 11347890 [TBL] [Abstract][Full Text] [Related]
32. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes. Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324 [TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. Schröder NW; Heine H; Alexander C; Manukyan M; Eckert J; Hamann L; Göbel UB; Schumann RR J Immunol; 2004 Aug; 173(4):2683-91. PubMed ID: 15294986 [TBL] [Abstract][Full Text] [Related]
34. Affinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology. de Haas CJ; Haas PJ; van Kessel KP; van Strijp JA Biochem Biophys Res Commun; 1998 Nov; 252(2):492-6. PubMed ID: 9826558 [TBL] [Abstract][Full Text] [Related]
35. Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. Denlinger LC; Fisette PL; Sommer JA; Watters JJ; Prabhu U; Dubyak GR; Proctor RA; Bertics PJ J Immunol; 2001 Aug; 167(4):1871-6. PubMed ID: 11489964 [TBL] [Abstract][Full Text] [Related]
36. Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. Andrä J; Lamata M; Martinez de Tejada G; Bartels R; Koch MH; Brandenburg K Biochem Pharmacol; 2004 Oct; 68(7):1297-307. PubMed ID: 15345319 [TBL] [Abstract][Full Text] [Related]
38. A novel lipopolysaccharide-binding protein (LBP) gene from sweetfish Plecoglossus altivelis: molecular characterization and its role in the immune response of monocytes/macrophages. Lu XJ; Chu CQ; Chen Q; Chen J Fish Shellfish Immunol; 2014 May; 38(1):111-8. PubMed ID: 24594008 [TBL] [Abstract][Full Text] [Related]
39. Liver transplantation and inflammation: is lipopolysaccharide binding protein the link? Fang H; Liu A; Dirsch O; Dahmen U Cytokine; 2013 Oct; 64(1):71-8. PubMed ID: 23958732 [TBL] [Abstract][Full Text] [Related]
40. Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor. Kloczewiak M; Black KM; Loiselle P; Cavaillon JM; Wainwright N; Warren HS J Infect Dis; 1994 Dec; 170(6):1490-7. PubMed ID: 7995989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]